BriaCell Therapeutics (OTCMKTS:BCTXF) Trading 0.3% Higher – Here’s Why

BriaCell Therapeutics Corp. (OTCMKTS:BCTXF)’s share price was up 0.3% during mid-day trading on Wednesday . The stock traded as high as $3.63 and last traded at $3.53. Approximately 35,112 shares traded hands during trading, an increase of 1,789% from the average daily volume of 1,859 shares. The stock had previously closed at $3.52.

BriaCell Therapeutics Trading Up 0.3 %

The firm has a 50-day moving average price of $2.73 and a 200-day moving average price of $1.46. The stock has a market capitalization of $2.73 million, a PE ratio of -0.01 and a beta of 1.09.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.